Analyst Ratings For Aileron Therap (NASDAQ:ALRN)
Today, William Blair initiated coverage on Aileron Therap (NASDAQ:ALRN) with a Outperform.
There are 4 buy ratings on the stock.
The current consensus rating on Aileron Therap (NASDAQ:ALRN) is Buy (Score: 3.00) with a consensus target price of $19.33 per share, a potential 51.28% upside.
Some recent analyst ratings include
- 7/24/2017-William Blair initiated coverage with a Outperform rating.
- 7/24/2017-Bank of America Corporation initiated coverage with a Buy rating.
- 7/24/2017-Canaccord Genuity initiated coverage with a Buy rating.
- 7/24/2017-Jefferies Group LLC initiated coverage with a Buy rating.
Recent Trading Activity for Aileron Therap (NASDAQ:ALRN)
Shares of Aileron Therap closed the previous trading session at 12.78 0.00 0.00% with 35,468 shares trading hands.